Alere Inc (ALR)

48.82
NYSE : Health Care
Prev Close 48.86
Day Low/High 48.64 / 48.90
52 Wk Low/High 31.47 / 49.53
Avg Volume 1.72M
Exchange NYSE
Shares Outstanding 87.00M
Market Cap 4.25B
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Alere Launches The Alere™ Malaria Ag P.f, The First-Ever Rapid Test To Screen Malaria Infection In Asymptomatic Individuals

New test provides powerful tool to help meet malaria eradication goals

Abbott CEO Upbeat Despite Ongoing Merger Headaches

Abbott CEO Upbeat Despite Ongoing Merger Headaches

Troubles at a plant acquired with St. Jude and continuing risks to closing the Alere deal linger over M&A spree.

Merger Challenges, FDA Concerns Dampen Abbott Gains Despite Strong First Quarter

Merger Challenges, FDA Concerns Dampen Abbott Gains Despite Strong First Quarter

Sales grew 29.7% in a year marked by acquisitions and new products, while comparable operations sales grew 3.2%.

Alere Stock Surging on Latest Abbott Agreement

Alere Stock Surging on Latest Abbott Agreement

Abbott will now pay a lower price to acquire Alere.

Can Abbott Outperform Despite Alere?

Can Abbott Outperform Despite Alere?

Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.

Abbott Laboratories Stock Downgraded by BMO

Abbott Laboratories Stock Downgraded by BMO

Abbott Laboratories downgraded to 'market perform.'

Alere Provides Update On Arriva Medical

Alere Receives FDA CLIA Waiver For Alere™ I RSV Rapid Molecular Test

First molecular test to detect RSV infection in 13 minutes or less now widely available in a broad range of healthcare settings

Abbott Shares Dip on Mixed Fourth-Quarter Earnings

Abbott Shares Dip on Mixed Fourth-Quarter Earnings

Abbott Labs' shares fell nearly 1% in premarket trading after the company reported mixed earnings results.

DEADLINE ALERT: Brower Piven Reminds Investors Of The January 13, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In Alere Inc. To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Investors Of The January 13, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In Alere Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of...

Alere Laboratory Receives ABFT Accreditation

Alere Laboratory Receives ABFT Accreditation

Accreditation covers both post-mortem and human performance toxicology test offerings

Husband of Top Trump Adviser Conway Said to Be a Finalist for U.S. Solicitor General

Husband of Top Trump Adviser Conway Said to Be a Finalist for U.S. Solicitor General

The lawyer is the husband of Trump adviser Kellyanne Conway and works in corporate litigation.

ALR SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Alere Inc. And A Lead Plaintiff Deadline Of January 13, 2017

ALR SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Alere Inc. And A Lead Plaintiff Deadline Of January 13, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased Alere Inc.

Alere Appeals Medicare Billing Decision

Alere Appeals Medicare Billing Decision

Shares of Alere were under pressure Thursday after appealing a decision that revoked its Arriva Medical unit's Medicare billing privileges.